本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

20.06
-0.3200-1.57%
盤後20.060.00000.00%19:30 EDT
成交量:185.56萬
成交額:3,741.88萬
市值:32.07億
市盈率:-7.07
高:20.51
開:20.40
低:19.87
收:20.38
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:1.29
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:3.84
市盈率(LYR):-6.75

資料載入中...

2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/04

重要事件披露

8-K - Current report
2021/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/26

重要事件披露

8-K - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/02/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

重要事件披露

8-K - Current report
2021/02/10

重要事件披露

8-K/A [Amend] - Current report
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals